Each pharmaceutical compound has its own characteristics and formulation challenges. InnoCore has many years of experience and case studies tailoring sustained release technologies to meet the requirements of a large variety of compounds.
Other. InnoCore has patented technologies suitable for a variety of compounds. Besides the show cases of small molecules, proteins and peptides, developments are on-going with RNA and DNA. By entrapment in a polymer matrix, the API can be protected from degradation by RNases and DNases. Contact us to discuss the possibilities.
Proteins, especially (monoclonal) antibodies, play an increasingly important role in today's pharmaceutical arena. A crucial...Read more
Small molecules still form the majority of all compounds used in pharmaceutical products. Often sustained release is used to...Read more